88 results
Page 3 of 5
8-K
EX-99.1
crfcf 2ufh6q
10 May 21
IDEAYA Biosciences, Inc. Reports First Quarter 2021
6:02am
8-K
EX-99.1
r246wd1f4qav
23 Mar 21
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2020
6:03am
8-K
EX-99.1
t0dp0hsudmbontdngtxw
17 Feb 21
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
6:05am
424B5
grc5 mu9ix
20 Jan 21
Prospectus supplement for primary offering
9:47pm
8-K
EX-99.1
4m9g9cqjjfb2u
11 Jan 21
Regulation FD Disclosure
6:19am
8-K
EX-99.1
164xnen
12 Nov 20
IDEAYA Biosciences, Inc. Reports Third Quarter 2020
6:06am
8-K
EX-99.1
fi1i1kll7bon9m9jo
24 Sep 20
Entry into a Material Definitive Agreement
6:02am
424B5
315ctrkcomoyv6y2j
12 Aug 20
Prospectus supplement for primary offering
4:13pm
8-K
EX-99.1
ce05v1ds t7bn4l6
12 Aug 20
IDEAYA Biosciences, Inc. Reports Second Quarter 2020
6:02am
8-K
EX-99.1
fzav51ww1dtzh
4 Aug 20
IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment
6:04am
8-K
EX-99.1
tq9y8a43083q0xbsg1
30 Jun 20
Departure of Directors or Certain Officers
6:05am
424B5
htcil3h
18 Jun 20
Prospectus supplement for primary offering
5:13pm
424B5
3yft0l
16 Jun 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.1
upui m8c0axnw2ahvvit
16 Jun 20
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
6:02am
8-K
EX-99.2
nuh70
16 Jun 20
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
6:02am
S-3
t8hqe kpp
1 Jun 20
Shelf registration
4:35pm